Ubiquitination and proteasome degradation of the E6 proteins of human papillomavirus types 11 and 18

Journal of General Virology

Volumn 85, Issue 6, 2004, Pages 1419-1426

  Stewart, Deborah ^a   Kazemi, Shirin ^b   Li, Suiyang ^b,d   Massimi, Paola ^c   Banks, Lawrence ^c   Koromilas, Antonis E ^b   Matlashewski, Greg ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^d Department of Biochemistry ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CELL PROTEIN; PROTEASOME; PROTEIN E6; PROTEIN P53; CYSTEINE PROTEINASE; DNA BINDING PROTEIN; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 11; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18; GREEN FLUORESCENT PROTEIN; MULTIENZYME COMPLEX; ONCOPROTEIN; PHOTOPROTEIN; UBIQUITIN;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CARCINOGENICITY; CELL PROLIFERATION; CONDYLOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; ONCOGENE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN STABILITY; PROTEIN TARGETING; SIGNAL TRANSDUCTION; UBIQUITINATION; UTERINE CERVIX CANCER; VIRUS TYPING; WART VIRUS; CELL LINE; METABOLISM; PHYSIOLOGY;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

CELL LINE; CYSTEINE ENDOPEPTIDASES; DNA-BINDING PROTEINS; GREEN FLUORESCENT PROTEINS; HUMANS; LUMINESCENT PROTEINS; MULTIENZYME COMPLEXES; ONCOGENE PROTEINS, VIRAL; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITIN;

EID: 2942670452     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.19679-0     Document Type: Article

References (26)

1. Banks, L., Matlashewski, G. & Crawford, L. (1986). Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression. Eur J Biochem 159, 529-534.
2. Gardiol, D., Kuhne, C., Glaunsinger, B., Lee, S. & Javier, R. (1999). Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene 18, 5487-5496.
3. Glausinger, B. A., Lee, S. S., Thomas, M., Banks, L. & Javier, R. (2000). Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins. Oncogene 19, 5270-5280.
4. Gross-Mesilaty, S., Reinstein, E., Bercovich, B., Tobias, K. E., Schwartz, A. L., Kahana, C. & Ciechanover, A. (1998). Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway. Proc Natl Acad Sci U S A 95, 8058-8063.
5. Huibregtse, J., Scheffner, M. & Howley, P. (1991). A cellular protein mediates association of p53 with the E6 oncoprotein of human papilloma types 16 or 18. EMBO J 10, 4129-4135.
6. Huibregtse, J., Scheffner, M. & Howley, P. (1993). Localization of the E6-AP regions that direct human papillomavirus E6 binding, association p53, and ubiquination of associated proteins. Mol Cell Biol 13, 4918-4927.
7. Kao, W. A., Beaudenon, S. L., Talis, A. L., Huibregtse, J. M. & Howley, P. M. (2000). Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase. J Virol 74, 6408-6417.
8. Kehmeier, E., Rühl, H., Voland, B., Stöppler, M. C., Androphy, E. & Stöppler, H. (2002). Cellular steady-state levels of "high-risk" but not "low-risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities. Virology 292, 72-87.
9. Kiyono, T., Hiraiwa, A., Fujita, M., Hayashi, Y., Akiyama, T. & Ishibashi, M. (1997). Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc Natl Acad Sci U S A 94, 11612-11616.
10. Lee, S. S., Weiss, R. & Javier, R. (1997). Binding of human virus oncoproteins to hD1g/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein. Proc Natl Acad Sci U S A 94, 6670-6675.
11. Lee, S. S., Glausinger, B., Mantovani, F., Banks, L. & Javier, R. T. (2000). Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-0RF1 and high-risk papillomavirus type 18 E6 oncoproteins. J Virol 74, 9680-9693.
12. Li, X., Zhao, X., Fang, Y., Jiang, X., Duong, T., Fan, C., Huang, C. & Kain, S. R. (1998). Generation of destabilized green fluorescent protein as a transcription reporter. J Biol Chem 273, 3470-3475.
13. Li, S., Labrecque, S., Gauzzi, M. C., Cuddihy, A. R., Wong, A. H. T., Pelligrini, S., Matlashewski, G. J. & Koromilas, A. E. (1999). The human papillomavirus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-α. Oncogene 18, 5727-5737.
14. Munoz, N., Bosch, X., de Sanjose, S., Herrero, R., Castellsague, X., Shah, K., Snijder, P. & Meijer, C. (2003). Epidemiological classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348, 518-527.
15. Nakagawa, S. & Huibregtse, J. (2000). Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin ligase. Mol Cell Biol 21, 8244-8253.
16. Pickart, C. (2001). Ubiquitin enters the new millennium - Meeting Review. Mol Cell 8, 499-504.
17. Pim, D. & Banks, L. (1999). HPV-18 E6I protein modulates the E6-directed degradation of p53 by binding to full-length HPV-18 E6. Oncogcne 18, 7403-7408.
18. Pim, D., Thomas, M., Javier, R., Gardiol, D. & Banks, L. (2000). HPV E6 targeted degradation of the discs large protein: evidence for the involvement of a novel ubiquitin ligase. Oncogene 19, 719-725.
19. Scheffner, M. & Whitaker, N. J. (2003). Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system. Semin Cancer Biol 13, 59-67.
20. Scheffner, M., Wernes, B., Huibregtse, J., Levine, A. & Howley, P. (1990). The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129-1136.
21. Storey, A., Pim, D., Murray, A., Osborn, K., Banks, L. & Crawford, L. (1988). Comparison of the in vitro transforming activities of human papillomavirus types. EMBO J 7, 1815-1820.
22. Thomas, M. & Banks, L. (1998). Inhibition of Bak-induced apoptosis by HPV-18E6. Oncogene 17, 2943-2954.
23. Treier, M., Staszewski, L. M. & Bohmann, D. (1994). Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 78, 787-798.
24. Werness, B., Levine, A. & Howley, P. (1990). Association of human papillomavirus types 16 and 18 proteins with p53. Science 248, 76-79.
25. zur Hausen, H. (1991). Viruses in human cancers. Science 254, 1167-1173.
26. zur Hausen, H. (1996). Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta 1288, F55-78.